Arch Pharmalabs Limited is a pharmaceutical company based in India, primarily engaged in the manufacturing and sale of Active Pharmaceutical Ingredients (APIs) and intermediates. Business SegmentsArch Pharmalabs operates across two primary verticals:Products: This segment includes the manufacture and sale of APIs and intermediates to both innovator and generic pharmaceutical companies in domestic and international markets. The company offers over 120 products across various therapeutic segments such as oncology, anti-diabetic, anti-hypertensive, and more.Services: The services include Contract Research and Manufacturing Services (CRAMS), which encompass custom synthesis, process development, analytical development, and clinical trial manufacturing.Market PresenceArch Pharmalabs has established nine multipurpose manufacturing facilities equipped with modern technologies.The company has formed strategic alliances with international firms like Codexis (USA) and DSM (Netherlands) to enh...
Checking authentication...
Checking authentication...
| P&L Statement | 2021 | 2022 | 2023 |
|---|---|---|---|
| Revenue | 706 | 1309 | 1341 |
| Cost of Material Consumed | 444 | 1052 | 1062 |
| Gross Margins | 37.11 | 19.63 | 20.81 |
| Change in Inventory | 21 | -68 | -37 |
| Employee Benefit Expenses | 74 | 75 | 69 |
| Other Expenses | 892 | 73 | 67 |
| EBITDA | -725 | 177 | 180 |
| OPM | -102.69 | 13.52 | 13.42 |
| Other Income | 2853 | -1 | 1 |
| Finance Cost | 231 | 98 | 35 |
| D&A | 28 | 25 | 23 |
| EBIT | -753 | 152 | 157 |
| EBIT Margins | -106.66 | 11.61 | 11.71 |
| PBT | 1869 | 52 | 122 |
| PBT Margins | 264.73 | 3.97 | 9.1 |
| Tax | - | - | - |
| PAT | 1869 | 52 | 122 |
| NPM | 264.73 | 3.97 | 9.1 |
| EPS | 123.03 | 3.42 | 7.8 |
| Financial Ratios | 2021 | 2022 | 2023 |
|---|---|---|---|
| Operating Profit Margin | -102.69 | 13.52 | 13.42 |
| Net Profit Margin | 264.73 | 3.97 | 9.1 |
| Earning Per Share (Diluted) | 123.03 | 3.42 | 7.8 |
Access the latest financial statements and performance reports
| Year | Report Title | Report Type | Action |
|---|---|---|---|
2023 | Arch Pharmalabs Ltd Shares | Financial Report | View Report |
Review comprehensive annual business overviews and performance summaries
| Year | Report Title | Report Type | Action |
|---|---|---|---|
2022 | Arch Pharmalabs Ltd Shares | Annual Report | View Report |
2021 | Arch Pharmalabs Ltd Shares | Annual Report | View Report |
Access essential information and documents to make informed investment decisions
Stay updated with upcoming events, conferences, and announcements
Access quarterly and half-yearly financial statements and reports
Download comprehensive annual reports and financial summaries
Access investor presentations, corporate briefings, and slideshows
The current market price of Arch Pharmalabs Ltd unlisted shares is ₹85 per share.
The minimum lot size is 250 Shares shares, and trades must be placed in multiples of this.
The shares have traded as high as ₹- and as low as ₹- over the past year.
The shares are held in NSDL & CDSL depositories under ISIN INE182F01017.
Arch Pharmalabs Ltd Shares's market capitalization is approximately ₹ 1330.08 crore.
The company has P/E ratio of 10.9, P/B ratio of 1.57, Debt-to-Equity ratio of 1.01, ROE of 14.57%.
The book value of Arch Pharmalabs Ltd Shares is ₹54.16 per share.
The face value of Arch Pharmalabs Ltd unlisted shares is ₹10 per share.
Arch Pharmalabs Ltd Shares has 156480000 shares outstanding.
Our blog provides insightful information about unlisted shares, offering a deeper understanding of how these assets work, their potential benefits, and the risks involved. Whether you're new to unlisted shares or looking to expand your knowledge, we cover topics such as investment strategies, valuation methods, market trends, and regulatory aspects. Stay updated with expert tips and guides to navigate the unlisted share market effectively.
Discover a variety of unlisted shares beyond the popular picks. Stay updated with real-time pricing, emerging opportunities, and market trends to diversify your portfolio and make confident investment decisions.
₹555
.avif&w=256&q=75)
₹468
.avif&w=256&q=75)
₹11250
.avif&w=256&q=75)
₹748
₹51
.png&w=750&q=75)
